LUPRON DEPOT-PED Drug Patent Profile
✉ Email this page to a colleague
When do Lupron Depot-ped patents expire, and what generic alternatives are available?
Lupron Depot-ped is a drug marketed by Abbvie Endocrine Inc and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in LUPRON DEPOT-PED is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lupron Depot-ped
A generic version of LUPRON DEPOT-PED was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for LUPRON DEPOT-PED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in LUPRON DEPOT-PED? | LUPRON DEPOT-PED excipients list |
DailyMed Link: | LUPRON DEPOT-PED at DailyMed |
Recent Clinical Trials for LUPRON DEPOT-PED
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
Parexel | Phase 2 |
US Patents and Regulatory Information for LUPRON DEPOT-PED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-003 | Apr 16, 1993 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-008 | Aug 15, 2011 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie Endocrine Inc | LUPRON DEPOT-PED KIT | leuprolide acetate | POWDER;INTRAMUSCULAR | 020263-005 | Jan 21, 1994 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |